Get the Stockscreener App
12.35
0.16%
0.02
After Hours:
12.35
Avid Bioservices Inc stock is traded at $12.35, with a volume of 2.14M.
It is up +0.16% in the last 24 hours and up +23.50% over the past month.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
See More
Previous Close:
$12.33
Open:
$12.32
24h Volume:
2.14M
Relative Volume:
1.20
Market Cap:
$788.89M
Revenue:
$139.91M
Net Income/Loss:
$-140.75M
P/E Ratio:
-275.06
EPS:
-0.0449
Net Cash Flow:
$-20.85M
1W Performance:
+1.06%
1M Performance:
+23.50%
6M Performance:
+41.30%
1Y Performance:
+159.18%
1-Day Range:
$12.30
$12.40
1-Week Range:
$12.18
$12.40
52-Week Range:
$4.0705
$12.48
Avid Bioservices Inc Stock (CDMO) Company Profile
Name
Avid Bioservices Inc
Sector
Industry
Phone
714.508.6100
Address
14191 MYFORD ROAD, TUSTIN, CA
Compare CDMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDMO
Avid Bioservices Inc
|
12.35 | 788.89M | 139.91M | -140.75M | -20.85M | -0.0449 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Initiated | William Blair | Mkt Perform |
| Mar-14-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-08-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-17-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-10-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-17-19 | Initiated | Stephens | Overweight |
| Oct-16-19 | Initiated | Craig Hallum | Buy |
| Jun-28-19 | Upgrade | Janney | Neutral → Buy |
| May-09-19 | Downgrade | Janney | Buy → Neutral |
View All
Avid Bioservices Inc Stock (CDMO) Latest News
Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.63 Consensus Target Price from Analysts - MarketBeat
Phocas Financial Corp. Purchases New Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices' SWOT analysis: biomanufacturing stock faces acquisition, growth challenges - Investing.com Nigeria
Avid Bioservices gains as holder opposes $12.50 a share takeover - MSN
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LP - MarketBeat
Avid Bioservices, Inc. (CDMO): A Bull Case Theory - Insider Monkey
Janney Montgomery Scott LLC Buys 1,800 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Punch and Associates Sends Letter to Board of Directors of Avid Bioservices, Inc - Marketscreener.com
Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc. - Voice Of Alexandria
Significant Shareholder Brock Pond Capital Partners Sends Letter to Avid Bioservices Company Board of Directors Opposing GHO/Ampersand Transaction - Longview News-Journal
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Bought by GSA Capital Partners LLP - MarketBeat
GHO, Ampersand to take Avid Bioservices private - BioCentury
GHO Capital Partners and Ampersand Capital Partners’ $1.1 Billion Acquisition of Avid Bioservices - Global Legal Chronicle
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand - MSN
Creative Planning Raises Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc.CDMO - Business Wire
Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeTime to Buy? - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, VINE, YOTA on Behalf of Shareholders - GlobeNewswire Inc.
Avid Bioservices Enters Agreement to Merge with Space Finco, Inc., Parent, and Merger Sub - Defense World
Avid Bioservices to be taken private by GHO, Ampersand in $1.1 billion deal - MSN
Avid Bioservices to Go Private in $1.1 Billion Deal - MSN
Avid Bioservices: Take-Private Deal At A Reasonable Price, Maintaining Buy (NASDAQ:CDMO) - Seeking Alpha
Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition - MSN
Avid Bioservices to be Acquired in $1.1 Billion Deal - Yahoo Finance
Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc. - cnhinews.com
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders - Business Wire
Avid Bioservices (NASDAQ:CDMO) Shares Gap UpStill a Buy? - MarketBeat
Rx Rundown: Avid Bioservices, Novo Nordisk, Zealand Pharma and more - MM+M Online
GHO, Ampersand take Avid Bioservices private for $1.1B - Axios
CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners - ForexTV.com
Avid Bioservices Shares Rise After $1.1B Buyout Offer - MarketWatch
Avid Bioservices To Be Acquired By GHO And Ampersand - Contract Pharma
PR News | JF, ICR Healthcare Work Avid's Go-Private DealThu., Nov. 7, 2024 - O'Dwyer's PR News
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand (NASDAQ:CDMO) - Seeking Alpha
Avid Bioservices' (CDMO) Sector Perform Rating Reaffirmed at Royal Bank of Canada - MarketBeat
William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO) - MarketBeat
Avid Bioservices to be sold to private equity firms for $1.1B - Endpoints News
GHO and Ampersand Capital to acquire Avid Bioservices - Yahoo Finance
PE to buy CDMO Avid Bioservices for $1.1 billion - BioProcess Insider
The five-year returns have been strong for Avid Bioservices (NASDAQ:CDMO) shareholders despite underlying losses increasing - Simply Wall St
$1.1B acquisition prompts RBC to downgrade avid bioservices stock By Investing.com - Investing.com UK
Avid Bioservices to go private in $1.1bn private equity deal - pharmaphorum
Hershey, Upwork And 3 Stocks To Watch Heading Into Thursday - Benzinga
Avid Bioservices to be taken private by GHO, Ampersand in $1.1 bln deal - Reuters
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction - GlobeNewswire
(CDMO) Technical Data - Stock Traders Daily
1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Bought by Emerald Advisers LLC - MarketBeat
Avid Bioservices Inc Stock (CDMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avid Bioservices Inc Stock (CDMO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
2,031 |
20,412 |
37,704 |
| Richieri Richard A. | Chief Operations Officer |
Oct 10 '24 |
Sale |
10.05 |
201 |
2,020 |
7,218 |
| Kwietniak Matthew R. | Chief Commercial Officer |
Oct 10 '24 |
Sale |
10.05 |
982 |
9,869 |
25,191 |
| Green Nicholas Stewart | President & CEO |
Oct 10 '24 |
Sale |
10.05 |
17,173 |
172,589 |
226,653 |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):